100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothCefpodoxime Proxetil 50mg + Clavulanic Acid 31.25mg
You Searched
Our Recommendation
Cefredrox CV 50/31.25mg Suspension 30ml
3,466+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Respiratory tract infection
Customers also bought
More About Podox CV 50 mg/31.25 mg Dry Syrup
Benefits
In Treatment of Respiratory tract infection Respiratory tract infections are those infections that can affect the sinuses, throat, airways or lungs. Podox CV 50 mg/31.25 mg Dry Syrup contains two different medicines, Cefpodoxime Proxetil and Clavulanic Acid, that work together to kill the bacteria that cause respiratory tract infections. Cefpodoxime Proxetil works by stopping the growth of bacteria. Clavulanic Acid reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How it works
Podox CV 50 mg/31.25 mg Dry Syrup is a combination of two medicines: Cefpodoxime Proxetil and Clavulanic Acid. Cefpodoxime Proxetil is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor that reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria.
Safe when prescribed by an expert: Podox CV 50 mg/31.25 mg Dry Syrup is safe to use in patients with kidney disease. No dose adjustment of Podox CV 50 mg/31.25 mg Dry Syrup is recommended. However, dose modifications may be required in children with severe kidney disease. Consult with your doctor.
Safe when prescribed by an expert: Podox CV 50 mg/31.25 mg Dry Syrup is safe to use in patients with liver disease. No dose adjustment of Podox CV 50 mg/31.25 mg Dry Syrup is recommended. However, consult with your child€™s doctor before giving Podox CV 50 mg/31.25 mg Dry Syrup to your child in case of a severe form of liver disease.
Manufacturer Address
Exeltis - Ordain Health Care Global Pvt Ltd , Khivraj Complex - II, 4th Floor, No: 480, Anna Salai, Nandanam, Chennai - 600 035, Tamil Nadu, India.
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
